Courtney Rubin is a Dermatology physician. OpenAlex indexes 22 publications with 243 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
221 Longwood Ave
Boston, MA 021155804
Telephone
617-732-4918Provider last certified this registry record 13 Apr 2022.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20258 payments
- ABBVIE INC.Program year202517 payments
- Teladoc Health, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
38.4%Corticosteroid27.5%Triamcinolone Acetonide78%Fluocinolone Acetonide22%Part D<11 patientsPolyene Antifungal5.7%Nystatin100%Part D<11 patients+ 1 more class in this area
Anti-infectives
29.4%Azole Antifungal18.5%Ketoconazole100%Part D≥26 patientsLincosamide Antibacterial5.7%Clindamycin Phosphate100%Part D<11 patients+ 1 more class in this area
Sensory organs
18.5%Corticosteroid18.5%Clobetasol Propionate72%Hydrocortisone28%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Need for Transparency and Careful Messaging Regarding the Potential for Benzoyl Peroxide Products to Form Benzene
Journal of Investigative Dermatology
2025 - Improving patient communication on sunscreen choice: Updating mechanistic misconceptions
JEADV Clinical Practice
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”